Wang JQ - Search Results

1

Paclitaxel resistance related to nuclear envelope structural sturdiness.

Smith ER, Wang JQ, Yang DH, Xu XX. Smith ER, et al. Among authors: wang jq. Drug Resist Updat. 2022 Dec;65:100881. doi: 10.1016/j.drup.2022.100881. Epub 2022 Oct 15. Drug Resist Updat. 2022. PMID: 36368286 Review.

2

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.

Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Teng QX, Chen ZS, Kong D, Yang DH. Ji N, et al. Among authors: wang jq. Front Pharmacol. 2018 Oct 30;9:1236. doi: 10.3389/fphar.2018.01236. eCollection 2018. Front Pharmacol. 2018. PMID: 30425643 Free PMC article.

3

Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.

Ji N, Yang Y, Lei ZN, Cai CY, Wang JQ, Gupta P, Xian X, Yang DH, Kong D, Chen ZS. Ji N, et al. Among authors: wang jq. Biochem Pharmacol. 2018 Dec;158:274-285. doi: 10.1016/j.bcp.2018.10.028. Epub 2018 Oct 26. Biochem Pharmacol. 2018. PMID: 30431011

4

Modulating ROS to overcome multidrug resistance in cancer.

Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS. Cui Q, et al. Among authors: wang jq. Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Drug Resist Updat. 2018. PMID: 30471641 Review.

5

Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible.

Cui Q, Yang Y, Ji N, Wang JQ, Ren L, Yang DH, Chen ZS. Cui Q, et al. Among authors: wang jq. Future Med Chem. 2019 Feb;11(4):323-336. doi: 10.4155/fmc-2018-0403. Epub 2019 Feb 25. Future Med Chem. 2019. PMID: 30802141 Review.

6

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.

Ji N, Yang Y, Cai CY, Wang JQ, Lei ZN, Wu ZX, Cui Q, Yang DH, Chen ZS, Kong D. Ji N, et al. Among authors: wang jq. Front Oncol. 2019 Jun 18;9:514. doi: 10.3389/fonc.2019.00514. eCollection 2019. Front Oncol. 2019. PMID: 31275850 Free PMC article.

7

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.

Cui Q, Cai CY, Wang JQ, Zhang S, Gupta P, Ji N, Yang Y, Dong X, Yang DH, Chen ZS. Cui Q, et al. Among authors: wang jq. Int J Mol Sci. 2019 Aug 22;20(17):4095. doi: 10.3390/ijms20174095. Int J Mol Sci. 2019. PMID: 31443367 Free PMC article.

8

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.

Liao D, Zhang W, Gupta P, Lei ZN, Wang JQ, Cai CY, Vera AA, Zhang L, Chen ZS, Yang DH. Liao D, et al. Among authors: wang jq. Molecules. 2019 Nov 30;24(23):4383. doi: 10.3390/molecules24234383. Molecules. 2019. PMID: 31801248 Free PMC article.

9

Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance.

Wu ZX, Yang Y, Teng QX, Wang JQ, Lei ZN, Wang JQ, Lusvarghi S, Ambudkar SV, Yang DH, Chen ZS. Wu ZX, et al. Among authors: wang jq. Cancers (Basel). 2020 Jan 12;12(1):186. doi: 10.3390/cancers12010186. Cancers (Basel). 2020. PMID: 31940916 Free PMC article.

10

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells.

Wang JQ, Li JY, Teng QX, Lei ZN, Ji N, Cui Q, Zeng L, Pan Y, Yang DH, Chen ZS. Wang JQ, et al. Cancers (Basel). 2020 Feb 18;12(2):466. doi: 10.3390/cancers12020466. Cancers (Basel). 2020. PMID: 32085398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,432 results

Search Page